化合物eCF506 T8499
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
500 mg | 1914078-41-3 | ¥13,300.00 | 询底价 |
50 mg | 1914078-41-3 | ¥4,660.00 | 询底价 |
100 mg | 1914078-41-3 | ¥6,650.00 | 询底价 |
2 mg | 1914078-41-3 | ¥523.00 | 询底价 |
1 mg | 1914078-41-3 | ¥346.00 | 询底价 |
1 mL | 1914078-41-3 | ¥1,120.00 | 询底价 |
5 mg | 1914078-41-3 | ¥995.00 | 询底价 |
25 mg | 1914078-41-3 | ¥3,180.00 | 询底价 |
10 mg | 1914078-41-3 | ¥1,560.00 | 询底价 |
Product Introduction
Bioactivity
英文名: eCF506
描述: eCF506 是一种高效的、口服具有活力的非受体酪氨酸激酶Src 抑制剂,其IC50<0.5 nM。
体内活性: eCF506, the first small molecule with subnanomolar IC50 for SRC that requires 3 orders of magnitude greater concentration to inhibit ABL.?eCF506 exhibits excellent water solubility, an optimal DMPK profile and oral bioavailability, halts SRC-associated neuromast migration in zebrafish embryos without inducing life-threatening heart defects, and inhibits SRC phosphorylation in tumor xenografts in mice.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 62.5 mg/mL (122.40 mM)
关键字: eCF-506 | eCF506 | Inhibitor | Src | eCF 506 | inhibit
相关产品: SU6656 | Beta-Hydroxyisovalerylshikonin | GW297361 | 1-Naphthyl PP1 | Tofacitinib | TPX-0046 | CSF1R-IN-2 | 1-Naphthyl PP1 hydrochloride | squarunkinA | OSI-930
相关库: Anti-Cancer Metabolism Compound Library | Angiogenesis related Compound Library | Anti-Cancer Compound Library | Bioactive Compounds Library Max | Kinase Inhibitor Library | Inhibitor Library | Tyrosine Kinase Inhibitor Library | Orally Active Compound Library | NO PAINS Compound Library | Bioactive Compound Library
化合物eCF506 T8499信息由TargetMol中国为您提供,如您想了解更多关于化合物eCF506 T8499报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途